This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (September 2023) |
Cogstate Brief Battery | |
---|---|
Synonyms | Cogstate Schizophrenia Battery |
The Cogstate Brief Battery (CBB) is a computer-based cognitive assessment used in clinical trials, healthcare, and academic research to measure neurological cognition. It was developed by Cogstate Ltd.
Assessment
The 15-minute assessment consists of four cognitive and neuropsychological tests: Detection, Identification, One Card Learning, and One Back. Each test measures functions in areas such as attention, visual learning, and working memory, and is designed specifically for repeated assessment.
Application
The assessment has been used to measure change in patients with mild cognitive impairment. and dementia, sports-related concussions, fatigue, and alcohol use, and schizophrenia. It can be taken by adults and children, and has minimal practice effects
In 2019, Cogstate and Eisai announced a partnership to make the test available outside the United States, for use in health care and other markets.
References
- ^ Stricker, Nikki H.; Lundt, Emily S.; Albertson, Sabrina M.; Machulda, Mary M.; Pudumjee, Shehroo B.; Kremers, Walter K.; Jack Jr., Clifford R.; Knopman, David S.; Petersen, Ronald C.; Mielke, Michelle M. (2020-01-01). "Diagnostic and Prognostic Accuracy of the Cogstate Brief Battery and Auditory Verbal Learning Test in Preclinical Alzheimer's Disease and Incident Mild Cognitive Impairment: Implications for Defining Subtle Objective Cognitive Impairment". Journal of Alzheimer's Disease. 76 (1): 261–274. doi:10.3233/JAD-200087. ISSN 1387-2877. PMC 7546579. PMID 32538841.
- Francesco, Davide De; Underwood, Jonathan; Anderson, Jane; Boffito, Marta; Post, Frank A.; Sachikonye, Memory; Mallon, Patrick W. G.; Haddow, Lewis; Vera, Jaime H.; Kunisaki, Ken M.; Sabin, Caroline A. (2020-12-28). "Correlation between computerised and standard cognitive testing in people with HIV and HIV-negative individuals". AIDS Care. 33 (10): 1296–1307. doi:10.1080/09540121.2020.1865518. ISSN 0954-0121. PMC 9448413. PMID 33356492. S2CID 229691208.
- Koyama, Alain K.; Hagan, Kaitlin A.; Okereke, Olivia I.; Weisskopf, Marc G.; Rosner, Bernard; Grodstein, Francine (2015). "Evaluation of a Self-Administered Computerized Cognitive Battery in an Older Population". Neuroepidemiology. 45 (4): 264–272. doi:10.1159/000439592. ISSN 0251-5350. PMC 4679513. PMID 26501919.
- ^ "Eisai to develop cognitive function test with Cogstate". www.biospectrumasia.com. Retrieved 2021-08-04.
- ^ Maruff, Paul; Lim, Yen Ying; Darby, David; Ellis, Kathryn A; Pietrzak, Robert H; Snyder, Peter J; Bush, Ashley I; Szoeke, Cassandra; Schembri, Adrian; Ames, David; Masters, Colin L (2013-12-23). "Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer's disease". BMC Psychology. 1 (1): 30. doi:10.1186/2050-7283-1-30. ISSN 2050-7283. PMC 4269990. PMID 25566378.
- ^ Zhong, Na; Jiang, Haifeng; Wu, Jin; Chen, Hong; Lin, Shuxing; Zhao, Yan; Du, Jiang; Ma, Xiancang; Chen, Ce; Gao, Chengge; Hashimoto, Kenji (2013-09-02). "Reliability and Validity of the CogState Battery Chinese Language Version in Schizophrenia". PLOS ONE. 8 (9): e74258. Bibcode:2013PLoSO...874258Z. doi:10.1371/journal.pone.0074258. ISSN 1932-6203. PMC 3759436. PMID 24023931.
- Patel, Sunita K.; Meier, Adrienne M.; Fernandez, Nathaniel; Lo, Tracy T. Y.; Moore, Colleen; Delgado, Nicole (2017-11-17). "Convergent and criterion validity of the CogState computerized brief battery cognitive assessment in women with and without breast cancer". The Clinical Neuropsychologist. 31 (8): 1375–1386. doi:10.1080/13854046.2016.1275819. ISSN 1385-4046. PMC 5507751. PMID 28080264.
- Alden, Eva C.; Pudumjee, Shehroo B.; Lundt, Emily S.; Albertson, Sabrina M.; Machulda, Mary M.; Kremers, Walter K.; Jack, Clifford R.; Knopman, David S.; Petersen, Ronald C.; Mielke, Michelle M.; Stricker, Nikki H. (2021). "Diagnostic accuracy of the Cogstate Brief Battery for prevalent MCI and prodromal AD (MCI A+T+) in a population-based sample". Alzheimer's & Dementia. 17 (4): 584–594. doi:10.1002/alz.12219. ISSN 1552-5279. PMC 8371696. PMID 33650308.
- Sicard, Veronik; Moore, Robert D.; Ellemberg, Dave (January 2019). "Sensitivity of the Cogstate Test Battery for Detecting Prolonged Cognitive Alterations Stemming From Sport-Related Concussions". Clinical Journal of Sport Medicine. 29 (1): 62–68. doi:10.1097/JSM.0000000000000492. ISSN 1050-642X. PMID 29023272. S2CID 23764316.
- "Repetitive Hits to the Head Tied to Depression, Poor Cognition". Medscape. Retrieved 2021-08-04.
- Goble, David; Christie, Candice Jo-Anne (2017-06-18). "Cognitive, physical and physiological responses of school boy cricketers to a 30-over batting simulation". Journal of Sports Sciences. 35 (12): 1148–1154. doi:10.1080/02640414.2016.1211731. ISSN 0264-0414. PMID 27467711. S2CID 20528850.
- Lupu, Tamar; Braw, Yoram; Sacher, Yaron; Ratmansky, Motti (2021-01-25). "Cogstate Brief Battery: Cognition and the feigning of cognitive impairment in chronic pain". Applied Neuropsychology: Adult. 29 (6): 1332–1343. doi:10.1080/23279095.2021.1873138. ISSN 2327-9095. PMID 33492175. S2CID 231703577.
- Falleti, Marina G.; Maruff, Paul; Collie, Alexander; Darby, David G.; McStephen, Michael (2003-12-01). "Qualitative similarities in cognitive impairment associated with 24 h of sustained wakefulness and a blood alcohol concentration of 0.05%". Journal of Sleep Research. 12 (4): 265–274. doi:10.1111/j.1365-2869.2003.00363.x. ISSN 0962-1105. PMID 14633237. S2CID 10003172.
- Sicard, Veronik; Hergert, Danielle C.; Reddy, Sharvani Pabbathi; Robertson-Benta, Cidney R.; Dodd, Andrew B.; Shaff, Nicholas A.; Stephenson, David D.; Yeates, Keith Owen; Cromer, Jason A.; Campbell, Richard A.; Phillips, John P. (n.d.). "Severity of Ongoing Post-Concussive Symptoms as a Predictor of Cognitive Performance Following a Pediatric Mild Traumatic Brain Injury". Journal of the International Neuropsychological Society. 27 (7): 686–696. doi:10.1017/S1355617720001228. ISSN 1355-6177. PMID 33243310. S2CID 227180771.
- "Apellis and Sobi strike a $1.25B deal in rare disease collaboration". www.bioworld.com. Retrieved 2021-08-03.